Patent · US Active

Heteroaryl inhibitors of PDE4

US11401286B2 · kind B2 · utility

2Cited by

6References

12Claims

0Family size

Assignee

Tetra Discovery Partners · US

Inventors

Mark E. Gurney · Grand Rapids, US
Timothy J. Hagen · Gurnee, US
Xuesheng Mo · Naperville, US
A. Samuel Vellekoop · Altamont, US
Donna L. Romero · Chesterfield, US
Robert Campbell · Niskayuna, US
Joel R. Walker · Tucson, US
Lei Zhu · Hefei, CN

Key dates

Filing date	Feb 4, 2020
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Feb 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/025
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.